Centre Hospitalier Intercommunal De Poissy Saint Germain
- Address
- Residence Les Maisonnees, 10 Rue Du Champ Gaillard, 78300 Poissy, France
Female Urogenital Diseases and Pregnancy Complications
The Centre Hospitalier Intercommunal De Poissy Saint Germain is conducting research aimed at reducing pregnancy‑related risks. A study evaluates whether routine use of aspirin early in gestation can lower the incidence of preterm preeclampsia among first‑time mothers who conceived through assisted reproductive technology.
- Prevention of preeclampsia
- Impact of early‑pregnancy interventions
- Outcomes after assisted reproductive technology
This work supports improved maternal health and may inform guidelines for obstetric care in France.
Nervous System Diseases
Investigators are assessing the long‑term safety of the oral agent tolebrutinib in adults living with multiple sclerosis, including both relapsing and progressive forms. The trial monitors tolerability and potential adverse effects over an extended period.
- Long‑term safety assessment
- Treatment of relapsing multiple sclerosis
- Management of progressive multiple sclerosis
- Real‑world effectiveness
Findings could expand therapeutic options for patients with chronic neuro‑inflammatory disease and guide clinicians across Europe.
Pathological Conditions, Signs and Symptoms
The research programme also addresses broader clinical concerns by tracking adverse events and symptom patterns in participants from both obstetric and neurology studies, ensuring comprehensive safety surveillance.
- Monitoring of clinical signs
- Reporting of adverse events
- Integration of safety data across specialties
- Patient‑reported outcome measures
This cross‑disciplinary approach enhances the centre’s capacity to protect participants and generate robust evidence for health policy.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 4 by active trials.
lock +3 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 978 other sites in France
Therapeutic Area Benchmark — France
Select a therapeutic area to compare against other sites in France.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: France
Market Share
Country: France
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Centre Hospitalier Intercommunal De Poissy Saint Germain
lock Showing 1 of 4 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Aspirin for the Prevention of Preeclampsia and Pregnancy outcomes in nulliparous women after Assisted Reproductive Technology. APPART trial | Centre Hospitalier Universitaire De Toulouse | Phase I | Recruiting | Aug 2023 | — |
IMP list
lock Showing 1 of 10 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Acetylsalicylic Acid | 1 | Unknown | 2023-08-02 | 2023-08-02 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.